...
首页> 外文期刊>Angewandte Chemie >Digitalis Research in Berlin-Buch—Retrospective and Perspective Views
【24h】

Digitalis Research in Berlin-Buch—Retrospective and Perspective Views

机译:柏林-布赫的洋地黄研究—回顾与透视图

获取原文
获取原文并翻译 | 示例
           

摘要

The following remarks consist partially of matter of fact, and purnally of opin-ion. The former will he permanent: the latter must van with the detetion of error, or the improvement of knowledge. I hazard them with diffidence, and hope they will he examined with can-dour." These declarations, which stem from the famous book "An Account of the Foxglove and some of its Medical Uses" by physician Wilikam Withering in 1785 in which he introduced preparations from digitalis leaves in the therapy of drops)(cardiac failure), are cited here by the senior author because of his awareness of the difficulties in presenting a balanced report on his life-lor.g research project on the further development of digitalis. His decision to devote himself to digitalis research originated at, the bedside, when as a physician he experienced the grim final stages of cardiac failure in which nj real help for the patients is nossible. Unfortunately, his research project did not fit into the research, program decreed by theMinistry of Science of the German Democratic Republic, so that he was ordered to stop ihe digitalis project in favor of biomem-brane studies. Fortunately, he got round the ban simpiy by labeling the digitalis-like acting steroids as probes for ihe ceil membrane-located Na~+ /K~+-transporting ATPase which he had just recognized as the digitalis target (receptor) enzyme. These and other ventures by the authors are collated here for the first time The aim of this review is to foster straightforward research for solving a major challenge: the development of steroidal drugs for the prevention and cure of cardiac failure.
机译:以下言论部分由事实构成,而主要由意见构成。前者将是永久的:后者必须随着错误的检测或知识的提高而发展。这些声明来自于医生威廉·威瑟林(Wilikam Withering)1785年著名的著作《毛地黄属植物及其医学用途的记载》,他在书中对此进行了介绍。这位资深作者在此引用了洋地黄叶在滴剂治疗(心力衰竭)中的制剂,因为他意识到在提出关于洋地黄的进一步发展的终生研究项目的平衡报告方面存在困难。他致力于洋地黄研究的决定起源于床头,当时,作为一名医生,他经历了心衰的严峻最后阶段,在此阶段无法为患者提供真正的帮助。不幸的是,他的研究项目不适合该研究,该计划由德意志民主共和国科学部(Department of German民主共和国)颁布,因此他被勒令停止洋地黄项目,转而支持生物膜研究。将洋地黄样起作用的类固醇标记为细胞膜定位的Na〜+ / K〜+转运ATPase的探针,他刚刚将其识别为洋地黄靶标(受体)酶。作者的这些和其他尝试首次在这里进行了整理。这篇综述的目的是开展直截了当的研究以解决一项重大挑战:开发用于预防和治疗心力衰竭的甾体药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号